title: Case study: to-BBB's G-Technology, getting the best from drug-delivery research with industry-academia partnerships.
abstract: To-BBB aims to develop efficacious treatments for patients with devastating neurological conditions based on to-BBB's proprietary G-Technology that safely enhances the delivery of drugs across the blood-brain barrier. Through strategic research collaborations, a small company such as to-BBB is able to deliver the high-quality research necessary to develop these novel treatments.
authors: To-BBB technologies BV. Bio Partner, Center II, Niels Bohrweg II, Bio-Science Park Leiden, 2333 CA Leiden, The Netherlands. gaillard@toBBB.com
authors: Pieter J
authors: PJ
authors: Gaillard
mesh_terms: D001709:Biotechnology / Q000458:organization & administration; D001812:Blood-Brain Barrier / Q000378:metabolism*; D002493:Central Nervous System Diseases / Q000188:drug therapy / Q000503:physiopathology; D003299:Cooperative Behavior; D016503:Drug Delivery Systems; D015195:Drug Design; D006801:Humans; D007373:Interinstitutional Relations; D012106:Research / Q000458:organization & administration